Atopic dermatitis;Dermatitis atopica

Alergologia e Inmunologia Clinica

Volumn 15, Issue 5, 2000, Pages 279-295

  Moreno Gimenez, J C ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; DISEASE ASSOCIATION; ECZEMA; HUMAN; PRURITUS; REVIEW; SKIN INFECTION; SPAIN;

EID: 0033678664     PISSN: 1575734X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Dermatitis atopica
2. Dermatitis atopica
3. Atopic dermatitis: An update
4. Atopic eczema in a multiracial country (Malaysia)
5. A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2.151 family members
6. Childhood eczema: Disease of the advantaged
7. Secular change in the occurrence of atopic dermatitis
8. Contributions and discussion presented at the 5th internatiohal Symposium on Atopic Dermatitis
9. Asthma, allergic rhinitis and atopic eczema in Finnish children and adolescents
10. Chromosome 11q13 and atopy underlting atopic eczema
11. Descendant family history of atopic dermatitis
12. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger
13. Maternal inheritance of atopic IgE responsiveness on chromosome 11q
14. Sweeting pattems in atopic dermatitis patients
15. Transepidermal water loss and skin surface hydratation in the non invasive assesment of stratum corneum function
16. Clinica de la dermatitis atopica
17. Is the origin of atopy linked to deficient conversion of 6 - Fatty acids to prostaglandin E1?
18. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis
19. Pharmacological abnormalities in atopic dermatitis
20. Inmmunopharmacology of the atopic diseases
21. A study of white dermographism in atopic dermatitis
22. Two types of mouse T-helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
23. Regulatory mechanism of in vitro IgE synthesis
24. Immune disrregulation in atopic eczema
25. Selective activation of circulating CD4+ lymphocytes in severe adult atopic dermatitis
26. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma
27. Atopic dermatitis: Clinical criteria
28. IgG subclasses in atopic dermatitis
29. Atopic dermatitis: Recent trends in pathogenesis and therapy
30. The role of eosinophils in the pathogenesis of atopic dermatitis: Eosinophil granule proteins as markers of disease activity
31. Eosinophil migration in atopic dermatitis
32. Atopic dermatitis: Triggering factors
33. The food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
34. Atopic dermatitis: Clinical relevance of food hipersensitivity reactions
35. Atopic dermatitis: Is it an allergic disease
36. Natural history of sensitizations in atopic dermatitis
37. A double blind controlled cross over trial of an antigen avoidance diet in atopic dermatitis
38. Egg and milk exclusion diets in atopic eczema
39. Atopic dermatitis: Role of food and house dust mite allergens
40. Six food diet for childhood atopic dermatitis
41. The influence of breast and artificial heeding on infantile eczema
42. Does breast feeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy
43. Prolonged breast feeding as prophylaxis for atopic disease
44. Effect of an allergy prevention programme on incidence of atopic symptoms in infancy: A prospective study of 159 'high risk' infants
45. Risk of developing atopic disease after early feeding with cow's milk based formula
46. Placebo controlled trial of essential fatty acid supplementation in atopic dermatitis
47. Exposure to house dust mites in homes of people with atopic dermatitis
48. House dust mite allergen on skin and sheets
49. House dust mites in atopic dermatitis
50. Evaluating the relevance of aeroalergen sesitization in atopic eczema with the atopy patch test: A randomized, double-blind multicenter study
51. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy
52. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects
53. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis
54. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin
55. Pityrosporum ovale and atopic dermatitis in children and young adults
56. IgE antibodies to Pityrosporum ovale in atopic dermatitis
57. Dermatitis de la cara y del cuello
58. Psicological sleep disturbance in children with atopic dermatitis: A case control study
59. Frequency and significance of the major and minor features of Hanifin and Rajka among patients with atopic dermatitis
60. Infreauricular fissures in atopic dermatitis
61. Krankheitsverlauf und psychosoziale ereignisse wahrend der stationaren behandlung atopisher ekzematiker
62. Role of emotional factor in adults with atopic dermatitis
63. Power relations in mother-child interactions in neurodermatitis constitucionalis atopica (atopic dermatitis)
64. Diagnosis features of atopic dermatitis
65. Trastornos geneticos y metabolicos asociados a dermatitis atopica
66. Trastornos geneticos y metabolicos asociados a dermatitis atopica
67. Clinical validation and guiliness for the SCORAD index: Consensus report of the European Task Force on atopic dermatitis
68. Factors influencing the prognosis of infantile eczema
69. Long term follow-up in atopic dermatitis
70. Breaking the cycle. How I manage difficult cases of atopic dermatitis
71. Tratamiento de la dermatitis atopica
72. Efficacy and safety of topical steroids in paediatric atopic dermatitis
73. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group
74. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis The Doxepin Study Group
75. Allergic contact dermatitis due to 5% doxepin cream
76. Treatment of itching in atopic eczema with antihistamines with low sedation profile
77. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum igE levels
78. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis
79. Cyclosporine in severe childhood atopic dermatitis: A multicenter study
80. Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children
81. Efectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis
82. A UVB phototherapy protocol with very low dose increments as a treatment of atopic dermatitis
83. Phosphodiesterase inhibition by Ro 10-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro
84. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome
85. A controlled trial of traditional Chinesse medicinal plants in widespread non-exudative atopic eczema
86. A controlled trial of traditional Chinesse herbal medicine in Chinesse patients with recalcitrant atopic dermatitis
87. Hypnotherapy as a treatment for atopic dermatitis in adults and children
88. A double blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymepentim as adjunctive treatment in atopic dermatitis
89. A novel therapy for atopic dermatitis with allergen-antibody complexes: A double blind, placebo controlled study